Lv1
40 积分 2025-09-06 加入
Pivotal trial characteristics and types of endpoints used to support Food and Drug Administration rare disease drug approvals between 2013 and 2022
2天前
已完结
Confirmatory evidence supporting single pivotal trial new drug approvals by the Food and Drug Administration, 2015 through 2023
2天前
待确认
Regulatory and Clinical Outcomes of Nononcology Accelerated Approvals
2天前
已完结
基于科学监管体系的中国药物临床试验实施质量国际评估比较
3天前
已完结
Efficacy assessment in phase I clinical trials: endpoints and challenges
3天前
已完结
Evolution of Evidence on Overall Survival Benefits of Cancer Drugs Included on the National Reimbursement Drug List of China，2005-2022: An Observational Study
1个月前
已关闭
Analysis of Phase I Clinical Trial Design of Anti-Cancer Agents
3个月前
已完结
An adaptive design for early clinical development including interim decision for single‐arm trial with external controls or randomized trial
3个月前
已完结
皖公网安备34019202002308
